PASSAGE ERASES 75 PERCENT OF WORKFORCE AFTER FDA BLOCKADE
Passage is conducting a strategic review. This is corporate speak for a mass layoff. The company is cutting 75 percent of its staff. The FDA blocked their gene therapy path. The dream of the pipeline died. Now only the wreckage remains.
The cost of regulatory failure is human livelihoods.
The wreckage includes.
- 75 percent of the workforce terminated.
- The primary gene therapy path blocked by the FDA.
- A strategic review to manage the fallout.
[ ADVERTISEMENT: YOUR DATA IS BEING SOLD WHILE YOU READ THIS ]